Articles On Global Health (ASX:GLH)

Luck’s a fortune, eh? Atomo Diagnostics’ (ASX:AT1) ASX listing had been in the offing for months, based on its rapid blood-based diagnostic device for HIV that’s the only self-administered HIV assay approved by the local Therapeutic Goods A...

  Medtech Atomo Diagnostics had an unusual start to life as a listed company today, holding a virtual bell-ringing as it became the first company to list on the ASX since January. But coronavirus concerns proved to be boon for the rapid blo...

Rapid blood test startup Atomo Diagnostics is playing its part in the fight against coronavirus, signing a deal with French diagnostics company, NG Biotech, to supply up 2.465 million of its rapid, blood-based COVID-19 tests in 2020. The s...

Melbourne-based Global Health (ASX: GLH) was already on a roll with strong revenue growth before the coronavirus outbreak, but now its software and videoconferencing platform for doctors is more relevant than ever. The company's practice...

The George Institute for Global Health has announced three Australian investors have committed $53 million to support the commercialisation of its research.

Ramifications from the spread of the coronavirus continue to cut deep. The World Health Organization (WHO) reports the total cases to number more than 60,000 worldwide, following the more than 13,332 extra cases Chinese authorities reported...

With triple the number of sepsis cases in Australia, small cap biotech company Cynata Therapeutics (ASX:CYP) hopes to wage a new war on blood infections. Last Friday the world learned blood infections were on the rise, with researchers show...

Asia is rising as a healthcare spender, matching incomes and the long-feared elderly population boom. The region is a major part of a surge in health spending that is expected over the next few years, as rising lifestyle illnesses and ages...

Health care is a huge part of the global economy and accounts for one of the fastest growing sectors. Traditionally, stocks under this sector fall under the defensive category. Health care sector includes various businesses, which broadly f...

In Australia, there are plenty of high-quality health care companies, most of which have delivered excellent returns. Investment in health care stocks is high yielding; however, it does include risks. If undergoing clinical studies fail to...

Introduction S&P/ASX 200 Index recently made its 52-week high level of $6875.50 on July 30, 2019. At the time of writing, the index was trading at $6653 (13:56 (UTC+11)), which is a ~3.2% decline from the 52-week high level. In between...

Australian Health Care is a dynamic sector with a potential to generate significant profits in the least amount of time, something, what investors eye for, while pouring cash in Stocks. In this article we will be digging into four Health Ca...

The Spark Festival, Australia’s largest event for startups, innovators and entrepreneurs, kicks off next week with more than 130 events, many of them free, happening over 17 days. Spark Festival 2019 runs October 10 – 27 and with so much...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

On 1 October 2005, I was only 20 metres away from a large bomb that went off in the heart of Kuta. The 2005 Bali bombings were a series of terrorist attacks across two sites in Jimbaran Bay and in Kuta - 30km away from each other, both in s...

Digital healthcare service has evolved as one of the fastest-growing industries in the modern era. Introduction of technology in medical science has emerged as one of the biggest blessings for human. Digitally connected network systems have...